Skip to content

Prospective Observational Study of Peri-implantation Serum hCG Levels

Prospective Observational Study of Peri-implantation Serum hCG Levels

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01184469
Enrollment
451
Registered
2010-08-19
Start date
2010-08-31
Completion date
2012-05-31
Last updated
2012-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

The purpose of this study is to prospectively define a set of data suitable for developing models of pregnancy viability. Those models will be based on serum hCG concentration measured during the peri-implantation period in patients that received fresh embryo transfer and those that received transfer of frozen-thawed embryos, and to compare and contrast these models. This may reveal insights into differences between these types of IVF cycles.

Detailed description

The current study seeks to examine the effect of the timing of implantation (as indicated by the first increase in serum hCG level) on the viability of pregnancies and to determine if such effect of timing differs between fresh embryo transfers and frozen-thawed embryos transfers. In this case, the timing of implantation will be measured through serum hCG analysis on days 3, 4, 5, and 7 after blastocyst transfer.

Interventions

None listed

Sponsors

Bruce Shapiro M.D.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* IVF patients (adults) who received blastocyst transfer

Exclusion criteria

* Those patients using different laboratories

Design outcomes

Primary

MeasureTime frameDescription
Ongoing pregnancy10 weeks gestationFetal heart motion at 10 weeks gestation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026